Direct Derm is a strategic clinical research partner to Science 37. Dr. Craft was previously the Chief Scientific Officer for Direct Derm and is now a Senior Advisor. He advises on medical informatics, strategic business development, and research-related partnerships for Direct Derm and is one of the practicing teledermatologists at Direct Derm.

Developing software tools (www.VisualDx.com) to help doctors make faster and more accurate diagnoses. VisualDx is a clinical decision support system proven to enhance diagnostic accuracy, aid therapeutic decisions, and improve patient safety in more than 1,500 hospitals and large clinics in the U.S. Dr. Craft served as a consultant from 2003 to 2012 and as Chief Medical Officer from 2012-2014. He now serves as Senior Strategic Advisor.

Science 37 uses advanced telemedicine technology and patient-centric innovative networked clinical research models to rapidly accelerate biomedical discovery and bring down the costs of clinical trials. In addition to our own researchers, we also work closely with top physician-scientists and leading telemedicine companies. S37 offers full support and end-to-end services for Networked Clinical Trials.Based in Los Angeles, we are focused on the development of networked patient-centric models for clinical research to rapidly accelerate biomedical discovery. We leverage partnerships with national mobile nursing companies, pharmacy chains, patient advocacy groups, virtual e-consenting, mobile devices, and other technology companies to maximize efficiency. Then, using design-thinking principles and rapid prototyping…S37 puts patients first and brings the best clinical trials right to their homes. One incredible benefit of the S37 approach is that by making trials better for patients, we ultimately make the process of biomedical discovery faster and less expensive. This means more safe and effective treatments will reach patients faster and cost less.Our proprietary technology platform, NORA (Network-Oriented Research Assistant), bridges the gap between traditional trial management software, an EMR, and an advanced telemedicine platform to support all participants in Networked Clinical Trials (NCTs). We utilize telemedicine, networked investigators, unique industry partnerships, proprietary software technologies, innovative patient engagement methods, industry-integrated software, and centralized regulatory processes to make clinical research faster, safer, and less expensive.

Staff Dermatologist and Clinical Associate Professor at UCLA School of Medicine in Dermatology